Inocras Applying Whole Genome Sequencing to Cancer Cell Residue Detection - San Diego Business Journal

Inocras Applying Whole Genome Sequencing to Cancer Cell Residue Detection - San Diego Business Journal

SAN DIEGO – Despite being officially in remission, cancer patients, particularly those with blood cancers like leukemia and lymphoma, may still have a small number of cancer cells in their bloodstream that cannot be detected by standard scans and lab tests. This condition, known as minimal residue disease or measurable residue disease (MRD), presents the […]

International study for patients after first failure of treatment. Genetic analysis and testing of medications similarly good. Progress in precision medicine.

Even in case of relapses or unsuccessful initial treatments, many blood cancer patients can benefit from modern precision medicine. An international study led by Austrian haematologists shows that genetic analyses and laboratory tests for the selection of active substances have enabled targeted treatment strategies to be developed for up to 80 percent of those affected.